Citations

Showing 10 of 108104 citations.

Dissecting aneurysm of the anterior inferior cerebellar artery in the internal auditory canal presenting with deafness without hemorrhage: A case report and literature review
Okada, Tomohisa, Makimoto, Kaisei, Yoshii, Riichiro, Yoshimoto, Koji, Moinuddin, F. M., Yamashita, Masaru, Arita, Kazunori, Moinuddin, F. M. , Okada, Tomohisa, Makimoto, Kaisei, Yoshii, Riichiro, Yoshimoto, Koji, Yamashita, Masaru, Arita, Kazunori

Mayo Clinic

Surgical Neurology International | March 11, 2022 | Volume: 13 | Issue: No issue available | Pages: 88

10.25259/sni_1220_2021 | PMID 35399907 Get It

Background: Anterior inferior cerebellar artery (AICA) aneurysms in the internal auditory canal (IAC) are rare. We have reported a case of dissecting AICA aneurysm in the IAC presenting initially with the eighth nerve palsy followed by the seventh nerve palsy without hemorrhage. Case Description: A 68-year-old woman presented with a sudden onset of vertigo accompanied by deafness and tinnitus on the right side that was preceded by intermittent right retroauricular pain 2 weeks before. Audiogram showed severe sensorineural hearing loss. Computed tomography and magnetic resonance imaging (MRI) indicated absence of prior subarachnoid hemorrhage. Magnetic resonance angiogram (MRA) suggested a tiny aneurysm at the fundus of the IAC accompanied with thinning of the lateral pontine segment of the AICA. Conservative treatment led to moderate improvement of the symptoms. However, the patient developed the right retroauricular pain again, followed by the right facial paralysis 5 months later but still without signs of hemorrhage on MRI. Digital subtraction angiogram showed dissecting aneurysm in the IAC. The patient was managed with oral steroids and direct intervention was avoided due to a risk of ischemia supposed by large area irrigated by the AICA. Follow-up MRA 18 months after the first presentation showed improvement in the narrowing of the AICA proximal to the aneurysm. The patient was functionally independent despite right-sided hearing loss and slight facial paresis. Conclusion: This report warns physicians that a dissecting AICA aneurysm without subarachnoid hemorrhage may cause eighth and seventh nerve palsy.
Cerebral sinus thrombosis as an initial symptom of acute promyelocytic leukemia: Case report and literature review
Salgado-Lopez, Laura, Custozzo, Amanda, Raviv, Nataly, Abdelhak, Tamer, Peris-Celda, Maria, Salgado-Lopez, Laura, Custozzo, Amanda, Raviv, Nataly, Abdelhak, Tamer, Peris-Celda, Maria

Mayo Clinic

Surgical Neurology International | March 11, 2022 | Volume: 13 | Issue: No issue available | Pages: 89

10.25259/sni_958_2021 | PMID 35399902 Get It

Background: Cerebral sinus thrombosis as presentation of acute promyelocytic leukemia (AMPL) is exceptional, with only three cases registered in the literature. Case Description: A 24-year-old female patient was transferred to our center after a car accident. The patient had a witnessed generalized seizure while driving. Computerized tomography (CT) demonstrated a temporal intraparenchymal hemorrhage and CT venogram diagnosed a cerebral sinus thrombosis on the left transverse and sigmoid sinus. The patient underwent surgical evacuation of the hematoma and was treated with anticoagulation 48 h after surgery. Pancytopenia alerted of a possible hematological disorder. The patient was subsequently diagnosed with AMPL and treated with arsenic trioxide. The patient had a complete neurological recovery with no postoperative complications. Conclusion: The management of cerebral sinus thrombosis in patients with AMPL remains controversial. The previous reported cases of cerebral sinus thrombosis preceding the diagnosis of AMPL are reviewed and treatment of cerebral sinus thrombosis with anticoagulation in the setting of intraparenchymal hemorrhage and bleeding disorders is also discussed.
Defining normal pouch function in patients with ileal pouch‐anal anastomosis: a pilot study
Quinn, Kevin P. , Busciglio, Irene, Burton, Duane D. , Lee, Yong S. , Heiken, Jay P. , Sheedy, Shannon P. , Raffals, Laura E. , Busciglio, Irene A, Inoue, Akitoshi , Raffals, Laura , Fletcher, Joel G.

Mayo Clinic

Alimentary Pharmacology & Therapeutics | March 11, 2022 | Volume: 55 | Issue: 12 | Pages: 1560-1568

10.1111/apt.16859 | PMID 35274320 Get It

SummaryBackgroundMost patients experience good functional outcomes following ileal pouch‐anal anastomosis (IPAA) for ulcerative colitis.AimWe aimed to determine if asymptomatic patients with an IPAA had findings consistent with normal defecation on standard objective anorectal tests.MethodsPatients 18–65 years old with IPAA and self‐reported healthy pouch function were recruited. Patients with chronic pouchitis, Crohn’s disease, anastomotic stricture, or indication for IPAA other than ulcerative or indeterminate colitis were excluded. Patients underwent an interview with an abbreviated Rome Questionnaire followed by high‐resolution ano‐pouch manometry, balloon expulsion test, pouch barostat, and magnetic resonance (MR) defecography.ResultsTwenty patients completed all testing. Six patients were excluded from the final analysis due to symptoms suggestive of pouch evacuation disorder on the abbreviated Rome Questionnaire (n = 2), structural abnormality on MR imaging (n = 3), or both (n = 1). Of the remaining 14 patients, mean anal resting pressure during high‐resolution manometry was 72 ± 16 mmHg, mean anal squeeze pressure was 247 ± 69 mmHg, and mean pouch‐anal gradient during the simulated evacuation was −27 ± 37 mmHg. The meantime to balloon expulsion was 54 seconds. During dynamic MR defecography, the mean descent of ano‐pouch junction was 2.6 cm, and mean pouch evacuation was 44.5% and 74.2% pre‐ and posttoilet phase, respectively.ConclusionsA substantial proportion of patients with IPAA and self‐reported healthy pouch function have anatomic and/or functional abnormalities of the pouch. In asymptomatic IPAA patients with an anatomically normal pouch, we have proposed normal parameters for high‐resolution ano‐pouch manometry, time to balloon expulsion, pouch barostat, and MR defecography.
Synuclein-One Study: Skin Biopsy Detection of Phosphorylated α-Synuclein for Diagnosis of Synucleinopathies
Gibbons, Christopher H. , Bellaire, Bailey, Moore, Dan H. , Levine, Todd, Gibbons, Christopher , Freeman, Roy L. , Adler, Charles H.

Mayo Clinic

Biomarkers in Medicine | March 11, 2022 | Volume: 16 | Issue: 7 | Pages: 499-509

10.2217/bmm-2021-0646 | PMID 35272481 Get It

Perioperative outcomes and survival after surgery for intramedullary spinal cord tumors: a single-institution series of 302 patients
Hersh, Andrew M., Patel, Jaimin, Pennington, Zach, Porras, Jose L., Goldsborough, Earl, Antar, Albert, Elsamadicy, Aladine A., Lubelski, Daniel, Wolinsky, Jean-Paul, Jallo, George, Gokaslan, Ziya L., Lo, Sheng-Fu Larry, Sciubba, Daniel M., Pennington, Zach , Antar, Albert , Pennington, Zach , Hersh, Andrew M., Patel, Jaimin, Porras, Jose L., Goldsborough, Earl F. , Elsamadicy, Aladine A., Lubelski, Daniel, Wolinsky, Jean-Paul, Jallo, George, Gokaslan, Ziya L., Lo, Sheng-Fu Larry, Sciubba, Daniel M.

Mayo Clinic

Journal of Neurosurgery: Spine | March 11, 2022 | Volume: 37 | Issue: 2 | Pages: 252-262

10.3171/2022.1.spine211235 | PMID 35213831 Get It

OBJECTIVE Intramedullary spinal cord tumors (IMSCTs) are rare neoplasms whose treatment is often technically challenging. Given the low volume seen at most centers, perioperative outcomes have been reported infrequently. Here, the authors present the largest single-institution series of IMSCTs, focusing on the clinical presentation, histological makeup, perioperative outcomes, and long-term survival of surgically treated patients. METHODS A cohort of patients operated on for primary IMSCTs at a comprehensive cancer center between June 2002 and May 2020 was retrospectively identified. Data on patient demographics, tumor histology, neuraxial location, baseline neurological status, functional deficits, and operative characteristics were collected. Perioperative outcomes of interest included length of stay, postoperative complications, readmission, reoperation, and discharge disposition. Data were compared across tumor histologies using the Kruskal-Wallis H test, chi-square test, and Fisher exact test. Pairwise comparisons were conducted using Tukey’s honest significant difference test, chi-square test, and Fisher exact test. Long-term survival was assessed across tumor categories and histological subtype using the log-rank test. RESULTS Three hundred two patients were included in the study (mean age 34.9 ± 19 years, 77% white, 57% male). The most common tumors were ependymomas (47%), astrocytomas (31%), and hemangioblastomas (11%). Ependymomas and hemangioblastomas disproportionately localized to the cervical cord (54% and 59%, respectively), whereas astrocytomas were distributed almost equally between the cervical cord (36%) and thoracic cord (38%). Clinical presentation, extent of functional dependence, and postoperative 30-day outcomes were largely independent of underlying tumor pathology, although tumors of the thoracic cord had worse American Spinal Injury Association (ASIA) grades than cervical tumors. Rates of gross-total resection were lower for astrocytomas than for ependymomas (54% vs 84%, p < 0.01) and hemangioblastomas (54% vs 100%, p < 0.01). Additionally, 30-day readmission rates were significantly higher for astrocytomas than ependymomas (14% vs 6%, p = 0.02). Overall survival was significantly affected by the underlying pathology, with astrocytomas having poorer associated prognoses (40% at 15 years) than ependymomas (81%) and hemangioblastomas (66%; p < 0.01) and patients with high-grade ependymomas and astrocytomas having poorer long-term survival than those with low-grade lesions (p < 0.01). CONCLUSIONS The neuraxial location of IMSCTs, extent of resection, and postoperative survival differed significantly across tumor pathologies. However, perioperative outcomes did not vary significantly across tumor cohorts, suggesting that operative details, rather than pathology, may have a stronger influence on the short-term clinical course, whereas pathology appears to have a stronger impact on long-term survival.
In Silico Analysis of Ion Channels and Their Correlation with Epithelial to Mesenchymal Transition in Breast Cancer
Parthasarathi, Kaushik , Mandal, Susmita, Singh, Smrita , Gundimeda, Seetaramanjaneyulu , Jolly, Mohit Kumar , Pandey, Akhilesh , Sharma, Jyoti , Pandey, Akhilesh , Singh, Smrita , Parthasarathi, K. T. Shreya

Mayo Clinic

Cancers | March 11, 2022 | Volume: 14 | Issue: 6 | Pages: 1444

10.3390/cancers14061444 | PMID 35326596 Get It

Uncontrolled growth of breast cells due to altered gene expression is a key feature of breast cancer. Alterations in the expression of ion channels lead to variations in cellular activities, thus contributing to attributes of cancer hallmarks. Changes in the expression levels of ion channels were observed as a consequence of EMT. Additionally, ion channels were reported in the activation of EMT and maintenance of a mesenchymal phenotype. Here, to identify altered ion channels in breast cancer patients, differential gene expression and weighted gene co-expression network analyses were performed using transcriptomic data. Protein–protein interactions network analysis was carried out to determine the ion channels interacting with hub EMT-related genes in breast cancer. Thirty-two ion channels were found interacting with twenty-six hub EMT-related genes. The identified ion channels were further correlated with EMT scores, indicating mesenchymal phenotype. Further, the pathway map was generated to represent a snapshot of deregulated cellular processes by altered ion channels and EMT-related genes. Kaplan–Meier five-year survival analysis and Cox regressions indicated the expression of CACNA1B, ANO6, TRPV3, VDAC1 and VDAC2 to be potentially associated with poor survival. Deregulated ion channels correlate with EMT-related genes and have a crucial role in breast cancer-associated tumorigenesis. Most likely, they are potential candidates for the determination of prognosis in patients with breast cancer.
The Effect of Anticoagulation on the Treatment of Dupuytren Contracture with Collagenase
Noland, Shelley S. , Paul, Aaron , Rizzo, Marco , Paul, Aaron W, Pflibsen, Lacey R.

Mayo Clinic

Plastic & Reconstructive Surgery | March 10, 2022 | Volume: 149 | Issue: 5 | Pages: 914e-920e

10.1097/prs.0000000000009038 | PMID 35271531 Get It

Background: There have been no formal studies of the use of collagenase clostridium histolyticum (Xiaflex; Endo Pharmaceuticals, Malvern, Pa.) in the anticoagulated patient. Previous study on its use excluded patients receiving anticoagulation therapy. This study reviewed the effects of anticoagulation use in patients undergoing collagenase clostridium histolyticum injection and cord rupture to determine safety and efficacy. Methods: The authors retrospectively reviewed patients receiving collagenase clostridium histolyticum injections for Dupuytren contracture between 2010 and 2017. Outcomes included type of anticoagulation, skin tear, tendon rupture, lymphadenopathy, sensory abnormality, hematoma, and bleeding. Results: A total of 388 injections were performed in 197 patients. The average clinical follow-up was 311 days. Fifty-two percent of patients (n = 201) were anticoagulated. The vast majority were taking aspirin (acetylsalicylic acid) (n = 182), followed by warfarin (n = 27), clopidogrel (n = 9), apixaban (n = 8), rivaroxaban (n = 4), and dabigatran (n = 2). There were 42 skin tears, 21 in the anticoagulated group. One tendon rupture occurred in the anticoagulated group (acetylsalicylic acid) and none occurred in the nonanticoagulated group (p = 0.34). No patients experienced sensory abnormalities, a hematoma requiring intervention, or uncontrollable bleeding. Conclusions: Anticoagulation is commonly encountered by hand surgeons treating Dupuytren contracture. There is no significant difference in complications in the anticoagulated patient versus the nonanticoagulated patient. It is safe to perform collagenase clostridium histolyticum injections for Dupuytren contracture in the anticoagulated patient, regardless of the type of anticoagulation. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
Factors Impacting the Success of Free Functioning Gracilis Muscle Transfer for Elbow Flexion in Brachial Plexus Reconstruction
Hinchcliff, Katharine M., Kircher, Michelle F., Bishop, Allen T., Spinner, Robert J., Shin, Alexander Y., Hinchcliff, Katharine M., Kircher, Michelle F., Bishop, Allen T., Spinner, Robert J., Shin, Alexander Y.

Mayo Clinic

Plastic & Reconstructive Surgery | March 10, 2022 | Volume: 149 | Issue: 5 | Pages: 921e-929e

10.1097/prs.0000000000009036 | PMID 35271536 Get It

Background: Free functioning muscle transfer is a reconstructive option to restore elbow flexion in brachial plexus injuries. The authors determined the impact of body mass index, age, and location of distal tendon attachment on elbow flexion strength after free functioning muscle transfer in traumatic brachial plexus injury patients. Methods: A retrospective review of patients who underwent free functioning muscle transfer for elbow flexion as part of their brachial plexus injury reconstruction with a minimum 2-year follow-up were evaluated. Outcomes assessed included elbow flexion strength (British Medical Research Council grade) and change in Disabilities of the Arm, Shoulder and Hand questionnaire and visual analogue scale pain scores. Results: One hundred six patients met inclusion criteria. The average age was 32 years, and the average body mass index was 27.1 kg/m2; 56.5 percent of patients achieved M3 or greater muscle grade using the authors’ strict modification of the British Medical Research Council scale. Disabilities of the Arm, Shoulder and Hand questionnaire scores improved from 45.7 to 38.8 (p < 0.05). Visual analogue scale pain scores decreased, but this trend did not obtain significance. Age and body mass index both had a significant negative impact on final free functioning muscle transfer grade (p < 0.05). Use of a distal tendon insertion led to improved muscle grade outcomes, with targeting of wrist extension being superior to finger flexion (p < 0.05). Simultaneous musculocutaneous nerve grafting did not significantly alter final elbow flexion strength. Conclusions: Increasing age and body mass index both imparted a deleterious effect on free functioning muscle transfer muscle grade. Distal muscle targets had better strength outcomes than when the biceps tendon was used. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.
HealthTree Cure Hub: A Patient-Derived, Patient-Driven Clinical Cancer Information Platform Used to Overcome Hurdles and Accelerate Research in Multiple Myeloma
Sweeney, Nathan W. , Ahlstrom, Jennifer M., Fonseca, Rafael, Davies, Faith E. , Thompson, Michael A. , Davies, Faith E , Thompson, Michael A , Sweeney, Nathan W. , Ahlstrom, Jennifer M., Fonseca, Rafael

Mayo Clinic

JCO Clinical Cancer Informatics | March 10, 2022 | Volume: No volume available | Issue: 6 | Pages: No page available

10.1200/cci.21.00141 | PMID 35271305 Get It

PURPOSEThe study of rare diseases, such as multiple myeloma (MM), often experiences unique research hurdles that can delay or prevent lifesaving discoveries. HealthTree Cure Hub is a first-in-class software program designed to overcome these potential research hurdles.METHODSWe assessed whether HealthTree Cure Hub improved four commonly experienced research hurdles such as (1) small numbers of patient accrual to clinical trials and research studies, (2) shallow and isolated data sets, (3) high costs to answer research questions, and (4) lack of long-term follow-up patient data.RESULTSAs of June 2021, HealthTree Cure Hub, with its unique portal features, has attracted 9,225 patients with MM and diverse demographic backgrounds. While completing an online health profile, patients shared comprehensive data, as well as provided consent to contribute data from electronic medical records. Portal use answered research questions using patient-driven real-world data. This also cultivated relationships with patients and established communication channels that enabled continual patient contact to allow for long-term follow-up.CONCLUSIONThese results suggest that a patient-driven data capture tool such as HealthTree Cure Hub will help alleviate common research hurdles, which, in turn, will accelerate MM research, develop new hypotheses, and ultimately improve survival.
Sub-lethal apoptotic stress enables mtDNA release during senescence and drives the SASP
Passos, João F. , Victorelli, Stella , Martini, Hélène , Riley, Joel S. , Shadel, Gerald S. , Netto, Jair Machado Espindola, Jurk, Diana , Lagnado, Anthony B. , Gomez, Lilian Sales , Saul, Dominik , Reed, Becca, Greaves, Laura C. , Masuda, Cláudio A. , Shae, Xue, Vizioli, Maria Grazia, Castillo, Alva Sainz, Jurk, Diana , Passos, João F , Saul, Dominik , Chapman, James , Salmonowicz, Hanna , Cloix, Catherine , Espíndola‐Netto, Jair Machado , Farr, Joshua N. , Mann, Derek A. , Khosla, Sundeep , Dai, Haiming , LeBrasseur, Nathan K. , Korolchuk, Viktor I. , Adams, Peter D. , Tait, Stephen W. G. , Kaufmann, Scott H. , Dou, Zhixun

Mayo Clinic

No container title available | March 10, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1247316/v1 Get It

Abstract Senescent cells drive age-related tissue dysfunction partially via the induction of a chronic senescence-associated secretory phenotype (SASP). Mitochondria are major regulators of the SASP; however, the underlying mechanisms have not been elucidated. Mitochondria also control apoptosis, a cell fate generally perceived as distinct from cellular senescence, which is apoptosis resistant. Here, we show that mitochondrial outer membrane permeability (MOMP) occurring in a small subset of mitochondria is a feature of cellular senescence. This process, called minority MOMP (miMOMP), depends on the formation of BAX and BAK macropores and results in release of mitochondrial DNA (mtDNA) into the cytosol, which in turn activates the cGAS/STING pathway, a major regulator of the SASP. Importantly, we found that inhibition of MOMP in vivo decreases inflammatory markers and improves healthspan parameters in aged mice. Our results propose the novel concept that apoptosis and senescence are regulated by similar mitochondrial-dependent mechanisms, and that sub-lethal mitochondrial apoptotic stress is a major driver of the SASP. We also provide proof-of-concept that inhibition of miMOMP may be a new therapeutic avenue to improve healthspan.